Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
14/05 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
30/04 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+12.07% | 958.65Cr | |
-0.17% | 558.45Cr | |
+8.67% | 550.13Cr | |
+6.77% | 523.84Cr | |
+27.91% | 484.4Cr | |
+23.26% | 461.02Cr | |
+2.73% | 412.81Cr | |
+7.31% | 404.95Cr | |
-0.23% | 327.99Cr |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- BofA Securities Downgrades Evotec to Neutral From Buy, Price Target is $13